Minimal Residual Disease Evaluation Using 8-Color Flow Cytometry Predicts Risk of Relapse in High-Risk and/or Young Myeloma Patients Who Receive Bortezomib Consolidation after Frontline Tandem Transplantation

被引:0
作者
Leblanc, Richard [1 ,2 ]
Ahmad, Imran [1 ,2 ]
Terra, Rafik [3 ]
Landais, Severine [4 ]
Nkoue, Celine [4 ]
Sebag, Michael [5 ]
Blanchard, Emilie Lemieux [6 ]
Bambace, Nadia M. [1 ,2 ]
Bernard, Lea [1 ,2 ]
Cohen, Sandra [1 ,2 ]
Delisle, Jean-Sebastien [1 ,2 ]
Kiss, Thomas L. [1 ,2 ]
Lachance, Silvy [7 ]
Roy, Denis-Claude [1 ,2 ]
Sauvageau, Guy [1 ,2 ,8 ]
Roy, Jean [1 ,2 ]
机构
[1] Univ Montreal, Dept Med, Div Hematol & Med Oncol, Stem Cell Transplant Program, Montreal, PQ, Canada
[2] Maisonneuve Rosemont Hosp, Montreal, PQ, Canada
[3] Maisonneuve Rosemont Hosp, Dept Hematol Lab, Immunol Lab, Montreal, PQ, Canada
[4] Maisonneuve Rosemont Hosp, Div Hematol & Med Oncol, Dept Med, Stem Cell Transplant Program, Montreal, PQ, Canada
[5] McGill Univ Hlth Ctr, Montreal, PQ, Canada
[6] Univ Montreal, Div Hematol & Med Oncol, Dept Med, CHUM, Montreal, PQ, Canada
[7] Hop Maison Neuve Rosemont, Div Hematol & Med Oncol, Dept Internal Med, Stem Cell Transplant Program, Montreal, PQ, Canada
[8] Univ Montreal, IRIC, Montreal, PQ, Canada
关键词
D O I
10.1182/blood-2018-99-112313
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4666
引用
收藏
页数:4
相关论文
empty
未找到相关数据